Heparin inhibits transcriptional activation by Fos and Jun oncoproteins.
Busch
S J
SJ
Merrell Dow Research Institute, Strasbourg, France.
Jackson
R L
RL
Sassone-Corsi
P
P
D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D015870:Gene Expression / Q000187:drug effects; D006025:Glycosaminoglycans / Q000378:metabolism; D006367:HeLa Cells; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D011401:Promoter Regions, Genetic; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics*; D016755:Proto-Oncogene Proteins c-jun / Q000235:genetics*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects*
D006025:Glycosaminoglycans; D016760:Proto-Oncogene Proteins c-fos; D016755:Proto-Oncogene Proteins c-jun; D006493:Heparin; D013755:Tetradecanoylphorbol Acetate